To include your compound in the COVID-19 Resource Center, submit it here.

MP0112: Phase I/IIa data

Top-line data from a dose-escalation U.S. Phase I/IIa trial in 18 patients showed that

Read the full 142 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE